Eastman Chemical (US.EMN)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.EMN · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | -133.3% | ↑ |
| ROE | 4.8% | ↓ |
| Cash Conversion | 30.0% | ↑ |
| D/E Ratio | 0.86 | → |
| Gross Margin | 21.1% | ↓ |
US.EMN (Eastman Chemical) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ----------------------------- FCF Conversion -133.3% ↑ ROE 4.8% ↓ Cash Conversion 30.0% ↑ D/E Ratio 0.86 → Gross Margin 21.1% ↓
Key Metrics
US.EMN (Eastman Chemical) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY-----------------------------FCF Conversion -133.3% ↑ROE 4.8% ↓Cash Conversion 30.0% ↑D/E Ratio 0.86 →Gross Margin 21.1% ↓Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies